AMA: Health implications of light at night 'serious'

June 21, 2012

(Medical Xpress) -- The American Medical Association is acknowledging the growing evidence of health problems associated with exposure to artificial light, and is taking action that could lead to more government funding of research in this area.

The AMA’s House of Delegates has voted to accept the recommendations of a report from the AMA Council on Science and Public , which address changes in lighting technologies and usage, recognition of the impact on sleep and sleep disorders, and further study of the possible link between light at night and cancer risk, obesity, and exacerbation of chronic diseases such as diabetes.

“It is a recognition by a major health body, the American Medical Association, that this is an emerging environmental issue that has a potentially large impact on the health of society,” says cancer epidemiologist Richard Stevens, professor in the UConn School of Medicine Department of Community Medicine and Health Care. “Based on an accumulation of evidence, this august body is now making the statement: ‘We take this seriously, and the public should take it seriously too.’”

The adoption of the council report’s recommendations by the AMA has the potential to influence federal grant money to study the health impact of artificial light at night.

Stevens was heavily involved in the writing of the report, titled “Light Pollution: Adverse Health Effects of Nighttime Lighting.” He is lead or co-author of nine of the research papers cited.

In scientific circles Stevens is widely credited with being the first to articulate the hypothesis that the increasing use of artificial light at night may be related to the high risk in the industrialized world. His research in that topic goes back 25 years.

“There’s no question that this light at night changes our physiology in the short term,” Stevens says. “We know that artificial light disrupts circadian rhythms. We’re learning more and more about the specifics of what that means. The clearest evidence is about the hormone melatonin. We’re lowering it, we’re even suppressing it completely, depending on the amount of light.”

Melatonin has been shown to inhibit breast cancer in laboratory rats. Stevens is careful to say that the changes in human physiology from artificial light, circadian disruption and melatonin suppression have not been proven to cause breast cancer. Instead he offers a judicial analogy:

“It’s guilty in a civil trial, but no verdict in a criminal trial. A reasonable jury would say there is a preponderance of evidence, but it’s not beyond a reasonable doubt at this point.”

Five years ago, the cancer research arm of the World Health Organization declared night shift work as a “probable carcinogen.” Stevens was on the panel of scientists that made that determination.

Explore further: Night shift might boost women's breast cancer risk: study

Related Stories

Night shift might boost women's breast cancer risk: study

May 29, 2012
(HealthDay) -- Women who work the night shift more than twice a week might be increasing their risk for breast cancer, Danish researchers find.

Excess weight in young adulthood predicts shorter lifespan

August 17, 2011
(Medical Xpress) -- Those 25-year-olds who are overweight now but think they will be fine as long as they lose weight eventually might need to reconsider. A study appearing online in the Journal of Adolescent Health finds ...

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.